Cargando…

Src controls castration recurrence of CWR22 prostate cancer xenografts

Recurrence of prostate cancer (CaP) after androgen-deprivation therapy continues to have the greatest impact on patient survival. Castration-recurrent (CR)-CaP is likely driven by the activation of androgen receptor (AR) through multiple mechanisms including induction of AR coregulators, AR mutants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Bing, Gillard, Bryan, Gao, Lingqiu, Eng, Kevin H, Gelman, Irwin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892383/ https://www.ncbi.nlm.nih.gov/pubmed/24403252 http://dx.doi.org/10.1002/cam4.144

Ejemplares similares

Metastatic phenotype in CWR22 prostate cancer xenograft following castration
por: Seedhouse, Steven J., et al.
Publicado: (2015)

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures
por: Chattopadhyay, Indranil, et al.
Publicado: (2016)

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model
por: Affronti, Hayley C., et al.
Publicado: (2017)

Androgen Receptor Activation in Castration-Recurrent Prostate Cancer: The Role of Src-Family and Ack1 Tyrosine Kinases
por: Gelman, Irwin H.
Publicado: (2014)

SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis
por: Liu, Yongzhong, et al.
Publicado: (2006)

A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer
por: Su, Bing, et al.
Publicado: (2014)

Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12
por: Su, Bing, et al.
Publicado: (2012)

Knockout of Akt1/2 suppresses the metastasis of human prostate cancer cells CWR22rv1 in vitro and in vivo
por: Su, Bing, et al.
Publicado: (2020)

Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks
por: Schoenherr, Christina, et al.
Publicado: (2017)

SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk
por: Muramatsu, Masashi, et al.
Publicado: (2018)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer
por: Kim, Seaho, et al.
Publicado: (2022)

Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer
por: Hashimoto, Kohei, et al.
Publicado: (2020)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

Methionine restriction breaks obligatory coupling of cell proliferation and death by an oncogene Src in Drosophila
por: Nishida, Hiroshi, et al.
Publicado: (2021)

miR‐1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src
por: Liao, Zhicong, et al.
Publicado: (2017)

MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans
por: VanOpstall, Calvin, et al.
Publicado: (2020)

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness
por: Xu, Fang‐Ping, et al.
Publicado: (2016)

Identification of Novel Focal Adhesion Kinase Substrates: Role for FAK in NFκB Signaling
por: Dwyer, Sheila Figel, et al.
Publicado: (2015)

In vivo imaging xenograft models for the evaluation of anti‐brain tumor efficacy of targeted drugs
por: Kita, Kenji, et al.
Publicado: (2017)

Patient‐derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment
por: Kuracha, Murali R., et al.
Publicado: (2016)

Combination of anginex gene therapy and radiation decelerates the growth and pulmonary metastasis of human osteosarcoma xenografts
por: Zhao, Kai, et al.
Publicado: (2018)

Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models
por: Hassan, Sara, et al.
Publicado: (2022)

Suppression of Chemotaxis by SSeCKS via Scaffolding of Phosphoinositol Phosphates and the Recruitment of the Cdc42 GEF, Frabin, to the Leading Edge
por: Ko, Hyun-Kyung, et al.
Publicado: (2014)

Novel chloroacetamido compound CWR-J02 is an anti-inflammatory glutaredoxin-1 inhibitor
por: Gorelenkova Miller, Olga, et al.
Publicado: (2017)

Novel galeterone analogs act independently of AR and AR-V7 for the activation of the unfolded protein response and induction of apoptosis in the CWR22Rv1 prostate cancer cell model
por: McCarty, David J., et al.
Publicado: (2017)

Gene expression profiling upon (212)Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model
por: Yong, Kwon J, et al.
Publicado: (2013)

miR-484 is associated with disease recurrence and promotes migration in prostate cancer
por: Lee, Daniel, et al.
Publicado: (2020)

Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion
por: Sachdev, Sanjay, et al.
Publicado: (2009)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
por: Pobel, Cedric, et al.
Publicado: (2021)

Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
por: Wang, Hui Qin, et al.
Publicado: (2017)

The Longitudinal Force Measurement of CWR Tracks with Hetero-Cladding FBG Sensors: A Proof of Concept
por: Shao, Li-Yang, et al.
Publicado: (2016)

A moonlighting function of a chitin polysaccharide monooxygenase, CWR-1, in Neurospora crassa allorecognition
por: Detomasi, Tyler C, et al.
Publicado: (2022)

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
por: Ventimiglia, Eugenio, et al.
Publicado: (2022)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Establishment of patient‐derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5‐fluorouracil
por: Lin, Yu‐Lin, et al.
Publicado: (2019)

Gene Expression in Single Cells Isolated from the CWR-R1 Prostate Cancer Cell Line and Human Prostate Tissue Based on the Side Population Phenotype
por: Gangavarapu, Kalyan J, et al.
Publicado: (2016)

A novel intraperitoneal therapy for gastric cancer with DFP‐10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model
por: Ando, Hidenori, et al.
Publicado: (2019)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bne10tmo84k4klsmgecn9hb2ch